Skip to application
All calculators and tools

Preparation. Administration. Evidence.

IV Dilution &
Medication Reference

Search 255 medications, read preserved historical references, and inspect separately reviewed preparation statements. Full monograph updates remain pending.

Version 6.4Release date 2026-11-04For healthcare professionals
Back to resultsA-Z list

Medication reference

Ampicillin

Monograph awaiting updateThis monograph will be updated in the future.

Jump to a section

Historical source. Current clinical review is incomplete. This monograph will be updated in the future.

Ampicillin (opens in a new tab)Original source URL: https://globalrph.com/dilution/ampicillin/ | Retrieved 2026-11-04

Source dates, location and integrity

This historical article is separate from the reviewed claim cards. Product formulations and source dates may differ.

Original source URL
https://globalrph.com/dilution/ampicillin/ (opens in a new tab)
Source date
Not established in the retrieved source
Retrieved
2026-11-04T19:45:58.048904+00:00
Source location
div.post-content
Packaged content SHA-256
8fe4c96a272c7e280b898aa50d135b23c174fe0e545741c818f76d9850e9e500
Original response SHA-256
59d9748ac258dd112d46d11687deae375814336bd296b267ded55cf3b50d63d9
Source body SHA-256
ba7393e444bbc95d318007566df5471a2620c7ca607bed92d88fee33799ee67f

AMPICILLIN

The authors make no claims of the accuracy of the information contained herein; and these suggested doses are not a substitute for clinical judgment. Neither GlobalRPh Inc. nor any other party involved in the preparation of this program shall be liable for any special, consequential, or exemplary damages resulting in whole or part from any user's use of or reliance upon this material. PLEASE READ THE DISCLAIMER CAREFULLY BEFORE ACCESSING OR USING THIS SITE. BY ACCESSING OR USING THIS SITE, YOU AGREE TO BE BOUND BY THE TERMS AND CONDITIONS SET FORTH IN THE DISCLAIMER.

Usual Diluents

NS

Standard Dilutions [Amount of drug] [Infusion volume] [Infusion rate]

[0 - 1 gram/ 50 ml] [30 minutes]
[Over 1 gram/ 100 ml] [30 minutes]

Stability / Miscellaneous

Label: REFRIGERATE.

DIRECTIONS FOR USE
Use only freshly prepared solutions. Intramuscular and intravenous injections should be administered within one hour after preparation since the potency may decrease significantly after this period.

For Intramuscular Use - Dissolve contents of a vial with the amount of Sterile Water for Injection, USP, or Bacteriostatic Water for Injection, USP, listed in the table below:

NDC 0781 Label
Claim
Recommended
Amount of
Diluent
Withdrawable
Volume
Concentration
(in mg/mL)
3400-95 125 mg 1.2 mL 1.0 mL 125 mg
3402-95 250 mg 1.0 mL 1.0 mL 250 mg
3407-95 500 mg 1.8 mL 2.0 mL 250 mg
3404-95 1 gram 3.5 mL 4.0 mL 250 mg
3408-95 2 gram 6.8 mL 8.0 mL 250 mg

While Ampicillin for Injection, USP, 1 g and 2 g, are primarily for intravenous use, they may be administered intramusculary when the 250 mg or 500 mg vials are unavailable. In such instances, dissolve in 3.5 or 6.8 mL Sterile Water for Injection, USP, or Bacteriostatic Water for Injection, USP, respectively. The resulting solution will provide a concentration of 250 mg per mL.

Ampicillin for Injection, USP, 125 mg, is intended primarily for pediatric use. It also serves as a convenient dosage form when small parenteral doses of the antibiotic are required.

For Direct Intravenous Use - Add 5 mL Sterile Water for Injection, USP, or Bacteriostatic Water for Injection, USP to the 125, 250, and 500 mg vials and administer slowly over a 3- to 5- minute period. Ampicillin for Injection, USP, 1 g or 2 g, may also be given by direct Intravenous administration. Dissolve in 7.4 or 14.8 mL Sterile Water for Injection, USP, or Bacteriostatic Water for Injection, USP, respectively, and administer slowly over at least 10 to 15 minutes. CAUTION: More rapid administration may result in convulsive seizures.

For Administration by Intravenous Drip - Reconstitute as directed above ( For Direct Intravenous Use) prior to diluting with Intravenous Solution. Stability studies on ampicillin sodium at several concentrations in various intravenous solutions indicate the drug will lose less than 10% activitiy at the temperatures noted for the time periods stated.

Stability:

Room Temperature (25° C)
Diluent Concentrations Stability
Periods
Sterile Water for Injection up to 30 mg/mL 8 hours
Isotonic Sodium Chloride up to 30 mg/mL 8 hours
5% Dextrose in Water 10 to 20 mg/mL 1 hour
5% Dextrose in Water up to 2 mg/mL 2 hours
5% Dextrose in 0.45% NaCl up to 2 mg/mL 2 hours
Lactated Ringer's Solution up to 30 mg/mL 8 hours
Refrigerated (4° C)
Diluent Concentrations Stability
Periods
Sterile Water for Injection 30 mg/mL 48 hours
Sterile Water for Injection up to 20 mg/mL 72 hours
Isotonic Sodium Chloride 30 mg/mL 24 hours
Isotonic Sodium Chloride up to 20 mg/mL 48 hours
Lactated Ringer's Solution up to 30 mg/mL 24 hours
5% Dextrose in Water up to 20 mg/mL 1 hour
5% Dextrose and 0.45% NaCl up to 10 mg/mL 1 hour

Only those solutions listed above should be used for the intravenous infusion of Ampicillin for injection, USP. The concentrations should fall within the range specified. The drug concentration and the rate and volume of the infusion should be adjusted so that the total dose of ampicillin is administered before the drug loses its stability in the solution in use.

Pharmacy Bulk Package- This glass vial contains 10 grams ampicillin and is designed for use in the pharmacy in preparing IV additives. Add 94 mL Sterile Water for Injection, USP. The resulting solution will contain 100 milligrams ampicillin activity per mL, and is stable up to one hour at room temperature. Diluting further within one hour from 5 mg to 10 mg per mL, the resulting solution will remain stable for 8 hours at room temperature or 72 hours under refrigeration.
CAUTION: NOT TO BE DISPENSED AS A UNIT.

DOSAGE AND ADMINISTRATION
Infections of the respiratory tract and soft tissues.
Patients weighing 40 kg (88 lbs) or more: 250 to 500 mg every 6 hours.

Patients weighing less than 40 kg (88 lbs): 25 to 50 mg/kg/day in equally divided doses at 6- to 8- hour intervals.

Infections of the gastrointestinal and genitourinary tracts (including those caused by Neisseria gonorrhoeae in females).
Patients weighing 40 kg (88 lbs) or more: 500 mg every 6 hours.

Patients weighing less than 40 kg (88 lbs): 50 mg/kg/day in equally divided doses at 6- to 8- hour intervals.

In the treatment of chronic urinary tract and intestinal infections, frequent bacteriological and clinical appraisal is necessary. Smaller doses than those recommended above should not be used. Higher doses should be used for stubborn or severe infections. In stubborn infections, therapy may be required for several weeks. It may be necessary to continue clinical and/or bacteriological follow-up for several months after cessation of therapy.

Urethritis in males due to N. gonorrhoeae.
Adults - Two doses of 500 mg each at an interval of 8 to 12 hours. Treatment may be repeated if necessary or extended if required.

In the treatment of complications of gonorrheal urethritis, such as prostatitis and epididymitis, prolonged and intensive therapy is recommended. Cases of gonorrhea with a suspected primary lesion of syphilis should have darkfield examinations before receiving treatment. In all other cases where concomitant syphilis is suspected, monthly serological tests should be made for a minimum of four months. The doses for the preceding infections may be given by either the intramuscular or intravenous route. A change to oral ampicillin may be made when appropriate.

Bacterial Meningitis
Adults and children - 150 to 200 mg/kg/day in equally divided doses every 3 to 4 hours. (Treatment may be initiated with intravenous drip therapy and continued with intramuscular injections.) The doses for other infections may be given by either the intravenous or intramuscular route.

Septicemia
Adults and children - 150 to 200 mg/kg/day. Start with intravenous administration for at least three days and continue with the intramuscular route every 3 to 4 hours.

Treatment of all infections should be continued for a minimum of 48 to 72 hours beyond the time that the patient becomes asymptomatic or evidence of bacterial eradication has been obtained. A minimum of 10-days treatment is recommended for any infection caused by Group A beta-hemolytic streptococci to help prevent the occurrence of acute rheumatic fever or acute glomerulonephritis.

HOW SUPPLIED
Ampicillin for Injection, USP for IM or IV Injection. Ampicillin sodium equivalent to 125, 250, 500 mg, 1, 2, or 10 grams ampicillin per vial.

NDC 0781-3400-95 125 mg vial packaged in 10s
NDC 0781-3402-95 250 mg vial packaged in 10s
NDC 0781-3407-95 500 mg vial packaged in 10s
NDC 0781-3404-95 1 gram vial packaged in 10s
NDC 0781-3408-95 2 gram vial packaged in 10s
NDC 0781-3409-95 10 gram Pharmacy Bulk Package packaged in 10s

Manufactured by
Sandoz GmbH, Kundl, Austria
for Sandoz Inc., Broomfield, CO 80020

Open this historical article on its own

Product identifiers and clinical review status

This monograph will be updated in the future. Historical material is available where present in the original sources; full current exact-product and claim-level review remains pending.

Exact formulation, concentration, container, manufacturer, regulatory identifiers, and a reproducible label snapshot have not all been reconciled.

What remains to be completed
  • Retrievable exact-product SPL XML with version, revision, retrieval date and reproducible hash
  • Clinically reviewed, individually identified statements with two exact source mappings
  • Exact formulation, strength, container, manufacturer/labeler, application and NDC reconciliation
  • Renal-function methods and dialysis/CRRT modality review where applicable
  • Mechanism provenance, clinical source disagreements and full medication-specific safety reconciliation

Supplemental historical fields

Restored-data provenance and review notes

Source release: 2026-08-31. Current clinical review is incomplete. Original uses of current, verified, or normalized describe the historical source. They do not inherit the status of separately reviewed statements. Product formulations and source dates can differ.

Current review annotations for historical renal, dialysis, mechanism, and product fieldsSeparate renal reference: Open Renal Dosing Master (opens in a new tab)
Renal
Status
not_locally_normalized
Original classification
adjustment_required
Entries
    General note
    Preserve the source-specific renal-function basis. An indexed CrCl table is not interchangeable with unindexed CrCl or eGFR. Generic advice to check a method does not identify the equation for a dose row.
    Dialysis
    Status
    no_local_structured_regimen
    Entries
      General note
      Named modality alone does not establish applicability. CRRT subtype, effluent rate, residual renal function, timing and interruptions require review. Historical absence is not evidence that no guidance exists.
      Mechanisms
      • Source kind
        first_look
        Local pointer
        /mechanism
        Original level
        class_level
        Provenance classification
        historical_class_level
        Label derived verified
        false
        Independently corroborated
        false
        Exact label section
        Not recorded
        Original source note
        Not recorded
        Review status
        historical_unverified
        Note
        Drug-specific wording in the old file is not proof of independent corroboration or an exact label locator. Consult separately published current mechanism claims where present.
      Future update
      Status
      pending_review
      Message
      This monograph will be updated in the future as current exact-product and claim-level review is completed.
      Source unavailable
      false
      Reason
      The historical content is restored; comprehensive contemporary verification remains incomplete.
      Historical first look: uses, mechanism, dosing context, and administration

      Recovered v5.1 source content; historical, awaiting current review.

      Id
      ampicillin
      Source IDH51-E4257EE0B45BB58096BCEA97
      Generic name
      Ampicillin
      Source IDH51-B866B050545AA025A7418961
      Class
      Antibacterial
      Source IDH51-5038666F3717755F8BACD101
      Subclass
      Aminopenicillin
      Source IDH51-3D58AF450601C8846488D9F6
      Primary uses
      1. Susceptible enterococcal, streptococcal, Listeria, and other infections
        Source IDH51-838B4C631B4DE1FA9D40B002
      Mechanism
      Beta-lactam binding to bacterial penicillin-binding proteins inhibits peptidoglycan cross-linking and cell-wall synthesis.
      Source IDH51-B03AC3E45BB196263469BB0D
      Mechanism level
      class_level
      Source IDH51-17437987EBCCCFB53DDFED3C
      Basic dosing orientation
      Adult | Existing preparation record; use current package insert for indication-specific selection | Common dose 1 to 2 g | Not normalized in the preparation record | See current package insert and professional guidance | IV infusion; Pediatric and neonatal | Existing preparation record; use current package insert for indication-specific selection | Weight-based dose; age and indication dependent | Not normalized in the preparation record | See current package insert and professional guidance | IV infusion
      Source IDH51-89FE200643B07893DFBD7FDC
      Administration orientation
      Infuse over 15 to 30 minutes
      Source IDH51-82224320885618538706284B
      Renal and population orientation
      Separate renal reference: Open Renal Dosing Master (opens in a new tab)Renal dose adjustment or interval modification is commonly required; verify the selected product label and patient-specific renal method.
      Source IDH51-12220CA6B52CC3B8E607B643
      Key safety orientation
      1. High sodium load may matter with large daily doses.
        Source IDH51-3E8F12E82C5B90CA730531BB
      2. Review renal function and indication-specific dosing.
        Source IDH51-B86D026F4FC251A04D7EE690
      Coverage path
      structured_local_snapshot
      Source IDH51-AB24A9B92ECC8A5B0758C275
      Coverage path label
      Structured GlobalRPh route snapshot
      Source IDH51-318A74D16A9CBA5EACD1F8C1
      Legacy title
      Ampicillin
      Source IDH51-D0583A3FC1965B3FA533E141
      Review note
      First-look orientation only. Verify indication, patient population, weight basis, organ function, exact IV product, dose, concentration, compatibility, rate, and current labeling before use.
      Source IDH51-0070D0CA9056D8F3119AD44D
      Search text
      Ampicillin Antibacterial Aminopenicillin Susceptible enterococcal, streptococcal, Listeria, and other infections Beta-lactam binding to bacterial penicillin-binding proteins inhibits peptidoglycan cross-linking and cell-wall synthesis. Adult | Existing preparation record; use current package insert for indication-specific selection | Common dose 1 to 2 g | Not normalized in the preparation record | See current package insert and professional guidance | IV infusion; Pediatric and neonatal | Existing preparation record; use current package insert for indication-specific selection | Weight-based dose; age and indication dependent | Not normalized in the preparation record | See current package insert and professional guidance | IV infusion Infuse over 15 to 30 minutes Renal dose adjustment or interval modification is commonly required; verify the selected product label and patient-specific renal method. High sodium load may matter with large daily doses. Review renal function and indication-specific dosing. Structured GlobalRPh route snapshot
      Source IDH51-A995EFEFB2C53E28540BBE79
      Official access mode
      search
      Source IDH51-24B88DC984EA2F167B12737F
      Official search query
      Ampicillin
      Source IDH51-74FC095C53B14F9E20B1C02F
      Official access reason
      A source-backed DailyMed search is available; select and confirm the exact IV product.
      Source IDH51-C8AA1ABCF8CCD0D4D62B559E

      No separate structured rows were bundled for IV push, continuous infusion, dialysis, CRRT. Historical article content and source links may cover these topics.

      Historical dilution and intermittent infusion preparation

      Recovered v5.1 source content; historical, awaiting current review.

      PopulationAmountReconstitutionDiluentFinal volumeConcentrationRateStabilityNotes
      Source IDH51-7F45408441C53F7526F47638
      Adult
      Source IDH51-3B98B8C61D27390D792B449D
      Common dose 1 to 2 g
      Source IDH51-771EF63FF37FA051578B88DB
      Reconstitute vial with Sterile Water for Injection as directed by vial strength.
      Source IDH51-506B81C5543C2CD778C32914
      NS preferred for many admixtures; confirm product-specific compatibility
      Source IDH51-A5DFFE5A5C0D8FE64D9FAC16
      50 to 100 mL
      Source IDH51-0C38D97EC1836C3781E268DD
      Commonly 10 to 30 mg/mL
      Source IDH51-3E2C9BDC4B10A19C29E287EA
      Infuse over 15 to 30 minutes
      Source IDH51-99FC2E572BD5E264B1D1A4F1
      Use the shorter of current product labeling, validated stability data, and the applicable USP <797> sterility-based BUD ceiling.
      Source IDH51-AF2E06A033100215AEEF75EB
      Use promptly after preparation; extended or continuous infusion requires validated stability data.
      Source IDH51-46FD953E7FFC48FF95C92975
      Source IDH51-8D7695F88FD64090A795821A
      Pediatric and neonatal
      Source IDH51-75B43902791833AFA58D66FB
      Weight-based dose; age and indication dependent
      Source IDH51-D7B4053C2D49FCAB2AF180CD
      Reconstitute per vial labeling.
      Source IDH51-E779DCA93E7C55CD6B657376
      NS or compatible fluid
      Source IDH51-B0BDCC803FCE6008319A4E46
      Volume based on weight and fluid allowance
      Source IDH51-668991A15B9092829FAAAA6A
      Institution-specific
      Source IDH51-F29BA2C806630856DDD5A7C1
      Infuse over 15 to 30 minutes
      Source IDH51-DFDFAC2639E83444C77416B0
      Use the shorter of current product labeling, validated stability data, and the applicable USP <797> sterility-based BUD ceiling.
      Source IDH51-812A535E9A9D4C88EB06DE25
      Meningitis and neonatal sepsis regimens use different dose and interval selections.
      Source IDH51-FDF39AC2590B759E6DA7812F

      Historical indication and population dosing

      Recovered tables and source-separated snapshots; full clinical revalidation remains pending.

      Existing dose and route snapshots

      RoutePopulationIndicationDoseIntervalDurationAdministrationSource levelNotes
      Source IDH51-F25E9DD42291E69EC0E6DC55
      IV infusion
      Source IDH51-3E1B95B32C22F8772D9F91DC
      Adult
      Source IDH51-19C5AAFADC86746E649861E5
      Existing preparation record; use current package insert for indication-specific selection
      Source IDH51-80687F89C5621A2B21B6B96C
      Common dose 1 to 2 g
      Source IDH51-9A764480CB757CE56A0D0CA1
      Not normalized in the preparation record
      Source IDH51-8D0443EAAEED3BAFF75DE8CD
      See current package insert and professional guidance
      Source IDH51-7F593EABF0069F190145CA0F
      Infuse over 15 to 30 minutes
      Source IDH51-DAF6810DCD5D97EF5F95B36F
      Existing GlobalRPh structured preparation snapshot
      Source IDH51-B466D7FE7834FF3C8EAD8C32
      Use promptly after preparation; extended or continuous infusion requires validated stability data.
      Source IDH51-260022B7B4CE3713C37BB189
      Source IDH51-F908383F871250FBD493DF30
      IV infusion
      Source IDH51-F9235F43F48E898AB025C271
      Pediatric and neonatal
      Source IDH51-F565A2361DFA0062921A5A0A
      Existing preparation record; use current package insert for indication-specific selection
      Source IDH51-1AA90C96E12E9C9EF9AEC0A4
      Weight-based dose; age and indication dependent
      Source IDH51-69214BF89A61566EE4F60658
      Not normalized in the preparation record
      Source IDH51-003D971F304C3B9B72995E4A
      See current package insert and professional guidance
      Source IDH51-E39DAEEFFCA9D6D8B24606E7
      Infuse over 15 to 30 minutes
      Source IDH51-740DF8E98778F58F70D46EE0
      Existing GlobalRPh structured preparation snapshot
      Source IDH51-7C5E0F617E03C0E5D32E43C5
      Meningitis and neonatal sepsis regimens use different dose and interval selections.
      Source IDH51-1365EE46D96E9FF6409BE93E

      Historical renal-function guidance

      Recovered v5.1 source content; historical, awaiting current review.

      Separate renal reference: Open Renal Dosing Master (opens in a new tab)
      Classification
      adjustment_required
      Source IDH51-51C7D9528F6F51A97365BBA5
      Summary
      Renal dose adjustment or interval modification is commonly required; verify the selected product label and patient-specific renal method.
      Source IDH51-FE843377EFB681B2AC8606D8
      Method note
      Use the renal function estimate and body-size convention specified by the selected label or institutional protocol. Do not interchange Cockcroft-Gault CrCl, indexed eGFR, and de-indexed eGFR without confirming the dosing source.
      Source IDH51-EAE147BEB9F25ACA74B89C3A

      Historical Common IV uses

      Recovered v5.1 source content; historical, awaiting current review.

      1. Susceptible enterococcal, streptococcal, Listeria, and other infections
        Source IDH51-B4D6A8A984A30BDF985AAA94

      Historical Warnings and safeguards

      Recovered v5.1 source content; historical, awaiting current review.

      Separate renal reference: Open Renal Dosing Master (opens in a new tab)
      1. High sodium load may matter with large daily doses.
        Source IDH51-064AFC8EE68FF3D89DA84F7D
      2. Review renal function and indication-specific dosing.
        Source IDH51-51997B0E25D8DABB263119DE

      Historical Monitoring

      Recovered v5.1 source content; historical, awaiting current review.

      Separate renal reference: Open Renal Dosing Master (opens in a new tab)
      1. Renal function
        Source IDH51-4CA8262CFFB91EC69DDDC308
      2. CBC and hepatic tests during prolonged therapy
        Source IDH51-2B52E10CAF3FDEB1C42B9337
      3. Hypersensitivity
        Source IDH51-0A066E86E3C85FF1223FA345

      Historical supplemental professional sources

      Recovered v5.1 source content; historical, awaiting current review.

      LabelUrlKind
      Source IDH51-A3FFEDC702231C94DC130D09
      UCSF adult antimicrobial dosing, non-dialysis
      Source IDH51-3D1F55805303A165886514AC
      https://idmp.ucsf.edu/adult-antimicrobial-dosing-non-dialysis (opens in a new tab)
      Source IDH51-C8896D7E25BE4C6C1B52EF0C
      Professional institutional guidance
      Source IDH51-B10CCA416A16300876FA1D55
      Source IDH51-C53835A307F5EFB521A13715
      UCSF antimicrobial dosing in intermittent and continuous hemodialysis
      Source IDH51-133D8A99FA0E192427C62DE2
      https://idmp.ucsf.edu/antimicrobial-dosing-intermittent-continuous-hemodialysis (opens in a new tab)
      Source IDH51-03035CE9AA07EC7D018256A7
      Professional institutional guidance
      Source IDH51-B0879C36DFA13EC2A02C1582
      Source IDH51-09A8B50504FB4DFD73330718
      UCSF pediatric antimicrobial dosing
      Source IDH51-3F00EEB27396C9C83BD717FB
      https://idmp.ucsf.edu/pediatric-antimicrobial-dosing-benioff-childrens-hospitals (opens in a new tab)
      Source IDH51-C4005400833340D19CDB5770
      Professional institutional guidance
      Source IDH51-F6A82A47E756FA8FC43328E9
      Source IDH51-4F651A414564CEE1182FCD22
      UCSF neonatal antimicrobial dosing
      Source IDH51-25C5C89C72EAF52E133B31EA
      https://idmp.ucsf.edu/neonatal-antimicrobial-dosing-benioff-childrens-hospitals (opens in a new tab)
      Source IDH51-B365EC7A33BF2EB40E47DD58
      Professional institutional guidance
      Source IDH51-1F9ADA09E1038356578CF05F
      Other recovered source fields and original editorial metadata

      Original status words such as current, verified, or normalized describe the historical source release. They do not change the clinical review status of this release.

      Catalog source fields

      Id
      ampicillin
      Source IDH51-0482EEA233C39EB48C0C6681
      Generic name
      Ampicillin
      Source IDH51-7B8D38BA13C4E7BD8991C062
      Brand names
      1. Omnipen
        Source IDH51-476184CE9B5F7F1AC3BE9CD5
      Class
      Antibacterial
      Source IDH51-8C3DD026008290BCD4C4247D
      Subclass
      Aminopenicillin
      Source IDH51-7301D448079008C612FF2E30
      Summary
      Time-dependent beta-lactam with relatively short solution stability at higher concentrations and room temperature.
      Source IDH51-42CE9E2A6774EFBAF695434B
      Populations
      1. Adult
        Source IDH51-7351AAA41D175A14F7509409
      2. Pediatric
        Source IDH51-D1AC0E71CF5416D356F872CA
      3. Neonatal
        Source IDH51-7078B6543079C0402838B875
      Evidence tier
      Core reference - verify current label
      Source IDH51-68EF6527FB0B67275C2BB317
      High alert
      false
      Source IDH51-2E20D1A9D23BD4D53315ADBA
      Hazardous
      false
      Source IDH51-4AB7AC588A0696123B5067D3
      Status
      Active
      Source IDH51-0DC56A10ACB744DB617BAE4D
      Reviewed
      2026-08-29
      Source IDH51-04D175ABBB800E1085E3F681
      Version added
      1.0
      Source IDH51-ACC3BCC7707B49F5E426CA4E
      Sources
      LabelUrlKind
      Source IDH51-EB591ED11868F8295B032565
      DailyMed label search
      Source IDH51-05550B8089D402E529DFD0D6
      https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Ampicillin (opens in a new tab)
      Source IDH51-6839C4CE24EA613A9FF2AD5D
      Primary
      Source IDH51-5723616C2EDB6484E605974B
      Source IDH51-759F58BE1F1DECB99E8B8943
      GlobalRPh legacy IV dilution monograph
      Source IDH51-6CDA8AD049B8C639CF0F6803
      legacy:auto
      Source IDH51-7EB597FD4EAA816C9DDB601E
      Legacy
      Source IDH51-0DC7FCC720236733607C09D6
      Legacy title
      Ampicillin
      Source IDH51-07BB906263A2E6178638F7F8
      Clinical release verification
      Audit version
      3.4
      Source IDH51-5EADFFF55C30E0C0F0BA6891
      Audited on
      2026-08-30
      Source IDH51-0796338BB3BB773F5CF73375
      Level
      amber
      Source IDH51-CA0129AF39B7C75B1F763115
      Release gate
      trusted_professional_source_present_exact_label_unconfirmed
      Source IDH51-F86837F814717FE29A22C4D9
      Exact current label candidate
      false
      Source IDH51-4C8797A99B41F47AC51953AB
      Numeric support ratio
      0
      Source IDH51-A90DE7167D8F78CE99891378
      Reference url count
      5
      Source IDH51-931A2AECBDD0C2FF631B8533
      Broken reference count
      0
      Source IDH51-2407296DED61080DDCD43EE4
      Point of use confirmation required
      true
      Source IDH51-6E084C2B4F29AACB610776CA
      Note
      Do not treat this record as a fully current product-specific monograph until the exact IV formulation and current sources are confirmed.
      Source IDH51-F3192D99F8D1CAD178805E18

      Dosing source fields

      Id
      ampicillin
      Source IDH51-B03C64B1AB9E0BAF885CFF36
      Generic name
      Ampicillin
      Source IDH51-A178C06BFA1AAF00E1C0E4FE
      Coverage status
      direct_official_label_access_plus_local_snapshot
      Source IDH51-C0B67ECD3C859F797EECF01B
      Package insert
      Query name
      Ampicillin
      Source IDH51-CA1808AA5091CC0B001C3C47
      Product and route must match
      true
      Source IDH51-6603CB4D8943BE73E01EE479
      Live current label enabled
      false
      Source IDH51-9451AF4EF08E610AB7391ADA
      Source priority
      Reviewed local summary when available, then a verified DailyMed label or product search when available, followed by professional references and institutional policy.
      Source IDH51-E4B93637DE9A0B5AC419E9AF
      Direct official label access enabled
      true
      Source IDH51-673EC49B1D7491C4A08504F5
      Outbound server request required
      false
      Source IDH51-ED1B7D19E7F27738E435C35B
      Local summary status
      not_bundled
      Source IDH51-18C1F967CB763C4A49B43277
      Clinical review
      Locally normalized
      false
      Source IDH51-E3CB311845EAD574BC2DDED5
      Reviewed
      2026-08-29
      Source IDH51-A295C38F828C1C0B45B0D829
      Status
      Direct official package-insert access enabled; indication-specific local normalization pending.
      Source IDH51-EAE8C30EF59266F0010B7316
      Clinical release verification
      Audit version
      3.4
      Source IDH51-39D8410C7974436EE5B02EC4
      Audited on
      2026-08-30
      Source IDH51-B0EEFD425CA7B20CDA55E4DF
      Level
      amber
      Source IDH51-07F843C6942D09092F7B4AF0
      Release gate
      trusted_professional_source_present_exact_label_unconfirmed
      Source IDH51-770FC9A59B1C82A039F943AF
      Exact current label candidate
      false
      Source IDH51-D3D30D212E6A18D6A4D8DDDB
      Numeric support ratio
      0
      Source IDH51-C83738C5BA746A1C927AC81F
      Reference url count
      5
      Source IDH51-4710212563B5E290424E1BA1
      Broken reference count
      0
      Source IDH51-2905B4D5877886083DFF1E50
      Point of use confirmation required
      true
      Source IDH51-03C374B61549973F08F0D6BC
      Note
      Do not treat this record as a fully current product-specific monograph until the exact IV formulation and current sources are confirmed.
      Source IDH51-500A2054C17AB17673882F2B
      Historical preparation assessment

      Recovered v5.1 source content; historical, awaiting current review.

      Id
      ampicillin
      Source IDH51-3048CBAA043485D2C34C0BFD
      Name
      Ampicillin
      Source IDH51-00686E4919D98DE13087DA6D
      Brands
      Omnipen
      Source IDH51-7E434E5052F9460192805F6B
      Therapeutic class
      Antibacterial
      Source IDH51-FC520474BD1E4A01A414C4B9
      Review version
      3.1
      Source IDH51-1FAA96F1D30E76540F6EF653
      Review date
      2026-08-30
      Source IDH51-AAAD6BB72EEEC16D74AE346C
      Release status
      structured_record_current_label_not_confirmed
      Source IDH51-93978A5B1B651EE7C50BFF27
      Market status
      Status
      no_current_us_iv_spl_confirmed
      Source IDH51-D9AB1DB6E4168F14E2EB04BF
      Basis
      No high-confidence current IV SPL was automatically selected; legacy information is segregated
      Source IDH51-85398162E2FFEE2331AF2311
      Ten point assessment
      Exact formulation
      Not established in the currently normalized record. Use the current-label panel before clinical use.
      Source IDH51-0491E169F103B5F21F80B232
      Reconstitution concentration
      Reconstitute vial with Sterile Water for Injection as directed by vial strength. Reconstitute per vial labeling.
      Source IDH51-C7BF7D4D445866A267E1ED0E
      Maximum or recommended final concentration
      Not established in the currently normalized record. Use the current-label panel before clinical use.
      Source IDH51-6C20787EC005FD8B6B919506
      Appropriate standardized containers
      50 to 100 mL Volume based on weight and fluid allowance
      Source IDH51-C56AD4A3FDCCA7D211956E11
      Adult dosing range
      Common dose 1 to 2 g Weight-based dose; age and indication dependent
      Source IDH51-E943F09A1F0A033EE2C13D03
      Pediatric dosing range
      Not established in the currently normalized record. Use the current-label panel before clinical use.
      Source IDH51-4E4A985354D3435335B54818
      Neonatal dosing range
      Not established in the currently normalized record. Use the current-label panel before clinical use.
      Source IDH51-6E2E5BF2A8794B499340F63D
      Infusion time
      Infuse over 15 to 30 minutes
      Source IDH51-DE8EF985D6B2E1E86E68EC9F
      Fluid restriction alternatives
      Not established in the currently normalized record. Use the current-label panel before clinical use.
      Source IDH51-E1A09835CAB7D83AFD316DE1
      Current manufacturer labeling
      Match confidence
      unresolved
      Source IDH51-C8F81046E61F6F12907A7624
      Field provenance
      Exact formulation
      Primary
      not_found
      Source IDH51-72879E75D13090F040E70053
      Reconstitution concentration
      Primary
      existing_structured_record
      Source IDH51-A8D7E8F8F008134D5946FC49
      Maximum or recommended final concentration
      Primary
      not_found
      Source IDH51-CF9013A510533FD757DAC2A0
      Appropriate standardized containers
      Primary
      existing_structured_record
      Source IDH51-27D807BCBD94424C00E8F1D2
      Adult dosing range
      Primary
      existing_structured_record
      Source IDH51-67777EB6FFB899F5AF8F6F62
      Pediatric dosing range
      Primary
      not_found
      Source IDH51-1CD110654DEFEE0AEA7F2C57
      Neonatal dosing range
      Primary
      not_found
      Source IDH51-9BB0809CC4310EEC14763460
      Infusion time
      Primary
      existing_structured_record
      Source IDH51-0B203C152EE3BBF57947F293
      Fluid restriction alternatives
      Primary
      not_found
      Source IDH51-5E4FA8B9F19B60F0BBD17C61
      Current manufacturer labeling
      Primary
      DailyMed search gateway
      Source IDH51-D1AE1D127F73A9AA5AE3F2E2
      Population applicability
      Adult
      Applicability
      supported_or_source_present
      Source IDH51-FE4F8C420FE32912986811B3
      Guide generation allowed
      true
      Source IDH51-0E33D6A24A91418617E048A9
      Pediatric
      Applicability
      supported_or_source_present
      Source IDH51-7DC9C1648726EA8BFD99EFB5
      Guide generation allowed
      false
      Source IDH51-DA01AF71988030DF65029F18
      Neonatal
      Applicability
      supported_or_source_present
      Source IDH51-FBFE8F0194C3A0330EACFF54
      Guide generation allowed
      false
      Source IDH51-93809DEDB86714E84C8821FD
      Route presence
      Structured dilution
      true
      Source IDH51-9291A2254F82BD4189D6D66C
      Iv push
      false
      Source IDH51-EE151CB4C2685E038E4C4226
      Continuous infusion
      true
      Source IDH51-CAEAECFBD406435949758E7D
      Pediatric source
      true
      Source IDH51-C7055CC4452635DAD7C9F10E
      Neonatal source
      true
      Source IDH51-DF8C5E8B0A6B9DED32930207
      Legacy reference
      Status
      not_available
      Source IDH51-D88E7D00DAFDB162C5B6653D
      Label resolution
      Status
      build_environment_network_unavailable
      Source IDH51-08FDDE5498D2820C54EF65DB
      Source files
      1. catalog.json
        Source IDH51-3F20E5C33D4814BED26265E9
      2. dosing.json
        Source IDH51-6911C463AFC5E534653D2477
      3. legacy-map.json
        Source IDH51-DEFFE50BDCA1405B2340B497
      Clinical release note
      Preparation instructions are released only at the evidence level shown. Legacy content remains visibly separate. Exact product, NDC, route, current labeling, and institutional policy must be confirmed.
      Source IDH51-993DC7F2F006C69B8A37A0B2
      Historical statement IDs and source locations

      These IDs identify recovered source units. They are not evidence-qualified clinical claims.

      Historical IDOriginal source locationStatus
      H51-0482EEA233C39EB48C0C6681catalog.json
      /records/19/id
      Historical; current review incomplete
      H51-7B8D38BA13C4E7BD8991C062catalog.json
      /records/19/generic_name
      Historical; current review incomplete
      H51-476184CE9B5F7F1AC3BE9CD5catalog.json
      /records/19/brand_names/0
      Historical; current review incomplete
      H51-8C3DD026008290BCD4C4247Dcatalog.json
      /records/19/class
      Historical; current review incomplete
      H51-7301D448079008C612FF2E30catalog.json
      /records/19/subclass
      Historical; current review incomplete
      H51-42CE9E2A6774EFBAF695434Bcatalog.json
      /records/19/summary
      Historical; current review incomplete
      H51-B4D6A8A984A30BDF985AAA94catalog.json
      /records/19/common_uses/0
      Historical; current review incomplete
      H51-7F45408441C53F7526F47638catalog.json
      /records/19/preparations/0
      Historical; current review incomplete
      H51-3B98B8C61D27390D792B449Dcatalog.json
      /records/19/preparations/0/population
      Historical; current review incomplete
      H51-771EF63FF37FA051578B88DBcatalog.json
      /records/19/preparations/0/amount
      Historical; current review incomplete
      H51-506B81C5543C2CD778C32914catalog.json
      /records/19/preparations/0/reconstitution
      Historical; current review incomplete
      H51-A5DFFE5A5C0D8FE64D9FAC16catalog.json
      /records/19/preparations/0/diluent
      Historical; current review incomplete
      H51-0C38D97EC1836C3781E268DDcatalog.json
      /records/19/preparations/0/final_volume
      Historical; current review incomplete
      H51-3E2C9BDC4B10A19C29E287EAcatalog.json
      /records/19/preparations/0/concentration
      Historical; current review incomplete
      H51-99FC2E572BD5E264B1D1A4F1catalog.json
      /records/19/preparations/0/rate
      Historical; current review incomplete
      H51-AF2E06A033100215AEEF75EBcatalog.json
      /records/19/preparations/0/stability
      Historical; current review incomplete
      H51-46FD953E7FFC48FF95C92975catalog.json
      /records/19/preparations/0/notes
      Historical; current review incomplete
      H51-8D7695F88FD64090A795821Acatalog.json
      /records/19/preparations/1
      Historical; current review incomplete
      H51-75B43902791833AFA58D66FBcatalog.json
      /records/19/preparations/1/population
      Historical; current review incomplete
      H51-D7B4053C2D49FCAB2AF180CDcatalog.json
      /records/19/preparations/1/amount
      Historical; current review incomplete
      H51-E779DCA93E7C55CD6B657376catalog.json
      /records/19/preparations/1/reconstitution
      Historical; current review incomplete
      H51-B0BDCC803FCE6008319A4E46catalog.json
      /records/19/preparations/1/diluent
      Historical; current review incomplete
      H51-668991A15B9092829FAAAA6Acatalog.json
      /records/19/preparations/1/final_volume
      Historical; current review incomplete
      H51-F29BA2C806630856DDD5A7C1catalog.json
      /records/19/preparations/1/concentration
      Historical; current review incomplete
      H51-DFDFAC2639E83444C77416B0catalog.json
      /records/19/preparations/1/rate
      Historical; current review incomplete
      H51-812A535E9A9D4C88EB06DE25catalog.json
      /records/19/preparations/1/stability
      Historical; current review incomplete
      H51-FDF39AC2590B759E6DA7812Fcatalog.json
      /records/19/preparations/1/notes
      Historical; current review incomplete
      H51-064AFC8EE68FF3D89DA84F7Dcatalog.json
      /records/19/warnings/0
      Historical; current review incomplete
      H51-51997B0E25D8DABB263119DEcatalog.json
      /records/19/warnings/1
      Historical; current review incomplete
      H51-4CA8262CFFB91EC69DDDC308catalog.json
      /records/19/monitoring/0
      Historical; current review incomplete
      H51-2B52E10CAF3FDEB1C42B9337catalog.json
      /records/19/monitoring/1
      Historical; current review incomplete
      H51-0A066E86E3C85FF1223FA345catalog.json
      /records/19/monitoring/2
      Historical; current review incomplete
      H51-7351AAA41D175A14F7509409catalog.json
      /records/19/populations/0
      Historical; current review incomplete
      H51-D1AC0E71CF5416D356F872CAcatalog.json
      /records/19/populations/1
      Historical; current review incomplete
      H51-7078B6543079C0402838B875catalog.json
      /records/19/populations/2
      Historical; current review incomplete
      H51-68EF6527FB0B67275C2BB317catalog.json
      /records/19/evidence_tier
      Historical; current review incomplete
      H51-2E20D1A9D23BD4D53315ADBAcatalog.json
      /records/19/high_alert
      Historical; current review incomplete
      H51-4AB7AC588A0696123B5067D3catalog.json
      /records/19/hazardous
      Historical; current review incomplete
      H51-0DC56A10ACB744DB617BAE4Dcatalog.json
      /records/19/status
      Historical; current review incomplete
      H51-04D175ABBB800E1085E3F681catalog.json
      /records/19/reviewed
      Historical; current review incomplete
      H51-ACC3BCC7707B49F5E426CA4Ecatalog.json
      /records/19/version_added
      Historical; current review incomplete
      H51-EB591ED11868F8295B032565catalog.json
      /records/19/sources/0
      Historical; current review incomplete
      H51-05550B8089D402E529DFD0D6catalog.json
      /records/19/sources/0/label
      Historical; current review incomplete
      H51-6839C4CE24EA613A9FF2AD5Dcatalog.json
      /records/19/sources/0/url
      Historical; current review incomplete
      H51-5723616C2EDB6484E605974Bcatalog.json
      /records/19/sources/0/kind
      Historical; current review incomplete
      H51-759F58BE1F1DECB99E8B8943catalog.json
      /records/19/sources/1
      Historical; current review incomplete
      H51-6CDA8AD049B8C639CF0F6803catalog.json
      /records/19/sources/1/label
      Historical; current review incomplete
      H51-7EB597FD4EAA816C9DDB601Ecatalog.json
      /records/19/sources/1/url
      Historical; current review incomplete
      H51-0DC7FCC720236733607C09D6catalog.json
      /records/19/sources/1/kind
      Historical; current review incomplete
      H51-07BB906263A2E6178638F7F8catalog.json
      /records/19/legacy_title
      Historical; current review incomplete
      H51-5EADFFF55C30E0C0F0BA6891catalog.json
      /records/19/clinical_release_verification/audit_version
      Historical; current review incomplete
      H51-0796338BB3BB773F5CF73375catalog.json
      /records/19/clinical_release_verification/audited_on
      Historical; current review incomplete
      H51-CA0129AF39B7C75B1F763115catalog.json
      /records/19/clinical_release_verification/level
      Historical; current review incomplete
      H51-F86837F814717FE29A22C4D9catalog.json
      /records/19/clinical_release_verification/release_gate
      Historical; current review incomplete
      H51-4C8797A99B41F47AC51953ABcatalog.json
      /records/19/clinical_release_verification/exact_current_label_candidate
      Historical; current review incomplete
      H51-C3D1185AFB1A1F809243B205catalog.json
      /records/19/clinical_release_verification/selected_setid
      Historical; current review incomplete
      H51-FB82FD3E589C27A82FF6E30Ecatalog.json
      /records/19/clinical_release_verification/selected_label_title
      Historical; current review incomplete
      H51-A90DE7167D8F78CE99891378catalog.json
      /records/19/clinical_release_verification/numeric_support_ratio
      Historical; current review incomplete
      H51-931A2AECBDD0C2FF631B8533catalog.json
      /records/19/clinical_release_verification/reference_url_count
      Historical; current review incomplete
      H51-2407296DED61080DDCD43EE4catalog.json
      /records/19/clinical_release_verification/broken_reference_count
      Historical; current review incomplete
      H51-6E084C2B4F29AACB610776CAcatalog.json
      /records/19/clinical_release_verification/point_of_use_confirmation_required
      Historical; current review incomplete
      H51-F3192D99F8D1CAD178805E18catalog.json
      /records/19/clinical_release_verification/note
      Historical; current review incomplete
      H51-62DE6CCE693C51342FD73872catalog.json
      /records/19/clinical_release_verification/dailymed_search_url
      Historical; current review incomplete
      H51-B03C64B1AB9E0BAF885CFF36dosing.json
      /records/19/id
      Historical; current review incomplete
      H51-A178C06BFA1AAF00E1C0E4FEdosing.json
      /records/19/generic_name
      Historical; current review incomplete
      H51-C0B67ECD3C859F797EECF01Bdosing.json
      /records/19/coverage_status
      Historical; current review incomplete
      H51-CA1808AA5091CC0B001C3C47dosing.json
      /records/19/package_insert/query_name
      Historical; current review incomplete
      H51-FD5C29CF06B492E082A4CA96dosing.json
      /records/19/package_insert/preferred_setid
      Historical; current review incomplete
      H51-6603CB4D8943BE73E01EE479dosing.json
      /records/19/package_insert/product_and_route_must_match
      Historical; current review incomplete
      H51-9451AF4EF08E610AB7391ADAdosing.json
      /records/19/package_insert/live_current_label_enabled
      Historical; current review incomplete
      H51-E4B93637DE9A0B5AC419E9AFdosing.json
      /records/19/package_insert/source_priority
      Historical; current review incomplete
      H51-673EC49B1D7491C4A08504F5dosing.json
      /records/19/package_insert/direct_official_label_access_enabled
      Historical; current review incomplete
      H51-ED1B7D19E7F27738E435C35Bdosing.json
      /records/19/package_insert/outbound_server_request_required
      Historical; current review incomplete
      H51-18C1F967CB763C4A49B43277dosing.json
      /records/19/package_insert/local_summary_status
      Historical; current review incomplete
      H51-51C7D9528F6F51A97365BBA5dosing.json
      /records/19/renal/classification
      Historical; current review incomplete
      H51-FE843377EFB681B2AC8606D8dosing.json
      /records/19/renal/summary
      Historical; current review incomplete
      H51-EAE147BEB9F25ACA74B89C3Adosing.json
      /records/19/renal/method_note
      Historical; current review incomplete
      H51-F25E9DD42291E69EC0E6DC55dosing.json
      /records/19/existing_route_snapshots/0
      Historical; current review incomplete
      H51-3E1B95B32C22F8772D9F91DCdosing.json
      /records/19/existing_route_snapshots/0/route
      Historical; current review incomplete
      H51-19C5AAFADC86746E649861E5dosing.json
      /records/19/existing_route_snapshots/0/population
      Historical; current review incomplete
      H51-80687F89C5621A2B21B6B96Cdosing.json
      /records/19/existing_route_snapshots/0/indication
      Historical; current review incomplete
      H51-9A764480CB757CE56A0D0CA1dosing.json
      /records/19/existing_route_snapshots/0/dose
      Historical; current review incomplete
      H51-8D0443EAAEED3BAFF75DE8CDdosing.json
      /records/19/existing_route_snapshots/0/interval
      Historical; current review incomplete
      H51-7F593EABF0069F190145CA0Fdosing.json
      /records/19/existing_route_snapshots/0/duration
      Historical; current review incomplete
      H51-DAF6810DCD5D97EF5F95B36Fdosing.json
      /records/19/existing_route_snapshots/0/administration
      Historical; current review incomplete
      H51-B466D7FE7834FF3C8EAD8C32dosing.json
      /records/19/existing_route_snapshots/0/source_level
      Historical; current review incomplete
      H51-260022B7B4CE3713C37BB189dosing.json
      /records/19/existing_route_snapshots/0/notes
      Historical; current review incomplete
      H51-F908383F871250FBD493DF30dosing.json
      /records/19/existing_route_snapshots/1
      Historical; current review incomplete
      H51-F9235F43F48E898AB025C271dosing.json
      /records/19/existing_route_snapshots/1/route
      Historical; current review incomplete
      H51-F565A2361DFA0062921A5A0Adosing.json
      /records/19/existing_route_snapshots/1/population
      Historical; current review incomplete
      H51-1AA90C96E12E9C9EF9AEC0A4dosing.json
      /records/19/existing_route_snapshots/1/indication
      Historical; current review incomplete
      H51-69214BF89A61566EE4F60658dosing.json
      /records/19/existing_route_snapshots/1/dose
      Historical; current review incomplete
      H51-003D971F304C3B9B72995E4Adosing.json
      /records/19/existing_route_snapshots/1/interval
      Historical; current review incomplete
      H51-E39DAEEFFCA9D6D8B24606E7dosing.json
      /records/19/existing_route_snapshots/1/duration
      Historical; current review incomplete
      H51-740DF8E98778F58F70D46EE0dosing.json
      /records/19/existing_route_snapshots/1/administration
      Historical; current review incomplete
      H51-7C5E0F617E03C0E5D32E43C5dosing.json
      /records/19/existing_route_snapshots/1/source_level
      Historical; current review incomplete
      H51-1365EE46D96E9FF6409BE93Edosing.json
      /records/19/existing_route_snapshots/1/notes
      Historical; current review incomplete
      H51-A3FFEDC702231C94DC130D09dosing.json
      /records/19/professional_sources/0
      Historical; current review incomplete
      H51-3D1F55805303A165886514ACdosing.json
      /records/19/professional_sources/0/label
      Historical; current review incomplete
      H51-C8896D7E25BE4C6C1B52EF0Cdosing.json
      /records/19/professional_sources/0/url
      Historical; current review incomplete
      H51-B10CCA416A16300876FA1D55dosing.json
      /records/19/professional_sources/0/kind
      Historical; current review incomplete
      H51-C53835A307F5EFB521A13715dosing.json
      /records/19/professional_sources/1
      Historical; current review incomplete
      H51-133D8A99FA0E192427C62DE2dosing.json
      /records/19/professional_sources/1/label
      Historical; current review incomplete
      H51-03035CE9AA07EC7D018256A7dosing.json
      /records/19/professional_sources/1/url
      Historical; current review incomplete
      H51-B0879C36DFA13EC2A02C1582dosing.json
      /records/19/professional_sources/1/kind
      Historical; current review incomplete
      H51-09A8B50504FB4DFD73330718dosing.json
      /records/19/professional_sources/2
      Historical; current review incomplete
      H51-3F00EEB27396C9C83BD717FBdosing.json
      /records/19/professional_sources/2/label
      Historical; current review incomplete
      H51-C4005400833340D19CDB5770dosing.json
      /records/19/professional_sources/2/url
      Historical; current review incomplete
      H51-F6A82A47E756FA8FC43328E9dosing.json
      /records/19/professional_sources/2/kind
      Historical; current review incomplete
      H51-4F651A414564CEE1182FCD22dosing.json
      /records/19/professional_sources/3
      Historical; current review incomplete
      H51-25C5C89C72EAF52E133B31EAdosing.json
      /records/19/professional_sources/3/label
      Historical; current review incomplete
      H51-B365EC7A33BF2EB40E47DD58dosing.json
      /records/19/professional_sources/3/url
      Historical; current review incomplete
      H51-1F9ADA09E1038356578CF05Fdosing.json
      /records/19/professional_sources/3/kind
      Historical; current review incomplete
      H51-E3CB311845EAD574BC2DDED5dosing.json
      /records/19/clinical_review/locally_normalized
      Historical; current review incomplete
      H51-A295C38F828C1C0B45B0D829dosing.json
      /records/19/clinical_review/reviewed
      Historical; current review incomplete
      H51-EAE8C30EF59266F0010B7316dosing.json
      /records/19/clinical_review/status
      Historical; current review incomplete
      H51-39D8410C7974436EE5B02EC4dosing.json
      /records/19/clinical_release_verification/audit_version
      Historical; current review incomplete
      H51-B0EEFD425CA7B20CDA55E4DFdosing.json
      /records/19/clinical_release_verification/audited_on
      Historical; current review incomplete
      H51-07F843C6942D09092F7B4AF0dosing.json
      /records/19/clinical_release_verification/level
      Historical; current review incomplete
      H51-770FC9A59B1C82A039F943AFdosing.json
      /records/19/clinical_release_verification/release_gate
      Historical; current review incomplete
      H51-D3D30D212E6A18D6A4D8DDDBdosing.json
      /records/19/clinical_release_verification/exact_current_label_candidate
      Historical; current review incomplete
      H51-EBF2B0B6680B220190ADF0B1dosing.json
      /records/19/clinical_release_verification/selected_setid
      Historical; current review incomplete
      H51-7A95CFEE8D49CF0C305ED88Edosing.json
      /records/19/clinical_release_verification/selected_label_title
      Historical; current review incomplete
      H51-C83738C5BA746A1C927AC81Fdosing.json
      /records/19/clinical_release_verification/numeric_support_ratio
      Historical; current review incomplete
      H51-4710212563B5E290424E1BA1dosing.json
      /records/19/clinical_release_verification/reference_url_count
      Historical; current review incomplete
      H51-2905B4D5877886083DFF1E50dosing.json
      /records/19/clinical_release_verification/broken_reference_count
      Historical; current review incomplete
      H51-03C374B61549973F08F0D6BCdosing.json
      /records/19/clinical_release_verification/point_of_use_confirmation_required
      Historical; current review incomplete
      H51-500A2054C17AB17673882F2Bdosing.json
      /records/19/clinical_release_verification/note
      Historical; current review incomplete
      H51-0B372A3B70CCD2191532EA24dosing.json
      /records/19/clinical_release_verification/dailymed_search_url
      Historical; current review incomplete
      H51-E4257EE0B45BB58096BCEA97first-look-v5.1.json
      /records/19/id
      Historical; current review incomplete
      H51-B866B050545AA025A7418961first-look-v5.1.json
      /records/19/generic_name
      Historical; current review incomplete
      H51-5038666F3717755F8BACD101first-look-v5.1.json
      /records/19/class
      Historical; current review incomplete
      H51-3D58AF450601C8846488D9F6first-look-v5.1.json
      /records/19/subclass
      Historical; current review incomplete
      H51-838B4C631B4DE1FA9D40B002first-look-v5.1.json
      /records/19/primary_uses/0
      Historical; current review incomplete
      H51-B03AC3E45BB196263469BB0Dfirst-look-v5.1.json
      /records/19/mechanism
      Historical; current review incomplete
      H51-17437987EBCCCFB53DDFED3Cfirst-look-v5.1.json
      /records/19/mechanism_level
      Historical; current review incomplete
      H51-89FE200643B07893DFBD7FDCfirst-look-v5.1.json
      /records/19/basic_dosing_orientation
      Historical; current review incomplete
      H51-82224320885618538706284Bfirst-look-v5.1.json
      /records/19/administration_orientation
      Historical; current review incomplete
      H51-12220CA6B52CC3B8E607B643first-look-v5.1.json
      /records/19/renal_and_population_orientation
      Historical; current review incomplete
      H51-3E8F12E82C5B90CA730531BBfirst-look-v5.1.json
      /records/19/key_safety_orientation/0
      Historical; current review incomplete
      H51-B86D026F4FC251A04D7EE690first-look-v5.1.json
      /records/19/key_safety_orientation/1
      Historical; current review incomplete
      H51-AB24A9B92ECC8A5B0758C275first-look-v5.1.json
      /records/19/coverage_path
      Historical; current review incomplete
      H51-318A74D16A9CBA5EACD1F8C1first-look-v5.1.json
      /records/19/coverage_path_label
      Historical; current review incomplete
      H51-5578DAC0E392C21C902AA547first-look-v5.1.json
      /records/19/official_label_url
      Historical; current review incomplete
      H51-D0583A3FC1965B3FA533E141first-look-v5.1.json
      /records/19/legacy_title
      Historical; current review incomplete
      H51-0070D0CA9056D8F3119AD44Dfirst-look-v5.1.json
      /records/19/review_note
      Historical; current review incomplete
      H51-A995EFEFB2C53E28540BBE79first-look-v5.1.json
      /records/19/search_text
      Historical; current review incomplete
      H51-5BBA4BE04F40788E1E554E8Afirst-look-v5.1.json
      /records/19/official_search_url
      Historical; current review incomplete
      H51-24B88DC984EA2F167B12737Ffirst-look-v5.1.json
      /records/19/official_access_mode
      Historical; current review incomplete
      H51-0218D514A7BF02909A8F4EC7first-look-v5.1.json
      /records/19/official_access_url
      Historical; current review incomplete
      H51-74FC095C53B14F9E20B1C02Ffirst-look-v5.1.json
      /records/19/official_search_query
      Historical; current review incomplete
      H51-C8AA1ABCF8CCD0D4D62B559Efirst-look-v5.1.json
      /records/19/official_access_reason
      Historical; current review incomplete
      H51-3048CBAA043485D2C34C0BFDpreparation-assessments-v3.8.json
      /19/id
      Historical; current review incomplete
      H51-00686E4919D98DE13087DA6Dpreparation-assessments-v3.8.json
      /19/name
      Historical; current review incomplete
      H51-7E434E5052F9460192805F6Bpreparation-assessments-v3.8.json
      /19/brands
      Historical; current review incomplete
      H51-FC520474BD1E4A01A414C4B9preparation-assessments-v3.8.json
      /19/therapeutic_class
      Historical; current review incomplete
      H51-1FAA96F1D30E76540F6EF653preparation-assessments-v3.8.json
      /19/review_version
      Historical; current review incomplete
      H51-AAAD6BB72EEEC16D74AE346Cpreparation-assessments-v3.8.json
      /19/review_date
      Historical; current review incomplete
      H51-93978A5B1B651EE7C50BFF27preparation-assessments-v3.8.json
      /19/release_status
      Historical; current review incomplete
      H51-D9AB1DB6E4168F14E2EB04BFpreparation-assessments-v3.8.json
      /19/market_status/status
      Historical; current review incomplete
      H51-85398162E2FFEE2331AF2311preparation-assessments-v3.8.json
      /19/market_status/basis
      Historical; current review incomplete
      H51-0491E169F103B5F21F80B232preparation-assessments-v3.8.json
      /19/ten_point_assessment/exact_formulation
      Historical; current review incomplete
      H51-C7BF7D4D445866A267E1ED0Epreparation-assessments-v3.8.json
      /19/ten_point_assessment/reconstitution_concentration
      Historical; current review incomplete
      H51-6C20787EC005FD8B6B919506preparation-assessments-v3.8.json
      /19/ten_point_assessment/maximum_or_recommended_final_concentration
      Historical; current review incomplete
      H51-C56AD4A3FDCCA7D211956E11preparation-assessments-v3.8.json
      /19/ten_point_assessment/appropriate_standardized_containers
      Historical; current review incomplete
      H51-E943F09A1F0A033EE2C13D03preparation-assessments-v3.8.json
      /19/ten_point_assessment/adult_dosing_range
      Historical; current review incomplete
      H51-4E4A985354D3435335B54818preparation-assessments-v3.8.json
      /19/ten_point_assessment/pediatric_dosing_range
      Historical; current review incomplete
      H51-6E2E5BF2A8794B499340F63Dpreparation-assessments-v3.8.json
      /19/ten_point_assessment/neonatal_dosing_range
      Historical; current review incomplete
      H51-DE8EF985D6B2E1E86E68EC9Fpreparation-assessments-v3.8.json
      /19/ten_point_assessment/infusion_time
      Historical; current review incomplete
      H51-E1A09835CAB7D83AFD316DE1preparation-assessments-v3.8.json
      /19/ten_point_assessment/fluid_restriction_alternatives
      Historical; current review incomplete
      H51-199023E50693272780AB6E29preparation-assessments-v3.8.json
      /19/ten_point_assessment/current_manufacturer_labeling/setid
      Historical; current review incomplete
      H51-F17FB71CBAF022A70358FF0Fpreparation-assessments-v3.8.json
      /19/ten_point_assessment/current_manufacturer_labeling/title
      Historical; current review incomplete
      H51-56B8D34D59C3B81BE8BB87B4preparation-assessments-v3.8.json
      /19/ten_point_assessment/current_manufacturer_labeling/published_date
      Historical; current review incomplete
      H51-D8F12CEDFFF8C7FCFC2C5039preparation-assessments-v3.8.json
      /19/ten_point_assessment/current_manufacturer_labeling/manufacturer
      Historical; current review incomplete
      H51-C8F81046E61F6F12907A7624preparation-assessments-v3.8.json
      /19/ten_point_assessment/current_manufacturer_labeling/match_confidence
      Historical; current review incomplete
      H51-F34DEEE44CB5B834721A86E9preparation-assessments-v3.8.json
      /19/ten_point_assessment/current_manufacturer_labeling/url
      Historical; current review incomplete
      H51-72879E75D13090F040E70053preparation-assessments-v3.8.json
      /19/field_provenance/exact_formulation/primary
      Historical; current review incomplete
      H51-A8D7E8F8F008134D5946FC49preparation-assessments-v3.8.json
      /19/field_provenance/reconstitution_concentration/primary
      Historical; current review incomplete
      H51-CF9013A510533FD757DAC2A0preparation-assessments-v3.8.json
      /19/field_provenance/maximum_or_recommended_final_concentration/primary
      Historical; current review incomplete
      H51-27D807BCBD94424C00E8F1D2preparation-assessments-v3.8.json
      /19/field_provenance/appropriate_standardized_containers/primary
      Historical; current review incomplete
      H51-67777EB6FFB899F5AF8F6F62preparation-assessments-v3.8.json
      /19/field_provenance/adult_dosing_range/primary
      Historical; current review incomplete
      H51-1CD110654DEFEE0AEA7F2C57preparation-assessments-v3.8.json
      /19/field_provenance/pediatric_dosing_range/primary
      Historical; current review incomplete
      H51-9BB0809CC4310EEC14763460preparation-assessments-v3.8.json
      /19/field_provenance/neonatal_dosing_range/primary
      Historical; current review incomplete
      H51-0B203C152EE3BBF57947F293preparation-assessments-v3.8.json
      /19/field_provenance/infusion_time/primary
      Historical; current review incomplete
      H51-5E4FA8B9F19B60F0BBD17C61preparation-assessments-v3.8.json
      /19/field_provenance/fluid_restriction_alternatives/primary
      Historical; current review incomplete
      H51-D1AE1D127F73A9AA5AE3F2E2preparation-assessments-v3.8.json
      /19/field_provenance/current_manufacturer_labeling/primary
      Historical; current review incomplete
      H51-FE4F8C420FE32912986811B3preparation-assessments-v3.8.json
      /19/population_applicability/adult/applicability
      Historical; current review incomplete
      H51-0E33D6A24A91418617E048A9preparation-assessments-v3.8.json
      /19/population_applicability/adult/guide_generation_allowed
      Historical; current review incomplete
      H51-7DC9C1648726EA8BFD99EFB5preparation-assessments-v3.8.json
      /19/population_applicability/pediatric/applicability
      Historical; current review incomplete
      H51-DA01AF71988030DF65029F18preparation-assessments-v3.8.json
      /19/population_applicability/pediatric/guide_generation_allowed
      Historical; current review incomplete
      H51-FBFE8F0194C3A0330EACFF54preparation-assessments-v3.8.json
      /19/population_applicability/neonatal/applicability
      Historical; current review incomplete
      H51-93809DEDB86714E84C8821FDpreparation-assessments-v3.8.json
      /19/population_applicability/neonatal/guide_generation_allowed
      Historical; current review incomplete
      H51-9291A2254F82BD4189D6D66Cpreparation-assessments-v3.8.json
      /19/route_presence/structured_dilution
      Historical; current review incomplete
      H51-EE151CB4C2685E038E4C4226preparation-assessments-v3.8.json
      /19/route_presence/iv_push
      Historical; current review incomplete
      H51-CAEAECFBD406435949758E7Dpreparation-assessments-v3.8.json
      /19/route_presence/continuous_infusion
      Historical; current review incomplete
      H51-C7055CC4452635DAD7C9F10Epreparation-assessments-v3.8.json
      /19/route_presence/pediatric_source
      Historical; current review incomplete
      H51-DF8C5E8B0A6B9DED32930207preparation-assessments-v3.8.json
      /19/route_presence/neonatal_source
      Historical; current review incomplete
      H51-D88E7D00DAFDB162C5B6653Dpreparation-assessments-v3.8.json
      /19/legacy_reference/status
      Historical; current review incomplete
      H51-08FDDE5498D2820C54EF65DBpreparation-assessments-v3.8.json
      /19/label_resolution/status
      Historical; current review incomplete
      H51-3F20E5C33D4814BED26265E9preparation-assessments-v3.8.json
      /19/source_files/0
      Historical; current review incomplete
      H51-6911C463AFC5E534653D2477preparation-assessments-v3.8.json
      /19/source_files/1
      Historical; current review incomplete
      H51-DEFFE50BDCA1405B2340B497preparation-assessments-v3.8.json
      /19/source_files/2
      Historical; current review incomplete
      H51-993DC7F2F006C69B8A37A0B2preparation-assessments-v3.8.json
      /19/clinical_release_note
      Historical; current review incomplete